Edge SB - Search Results

1

Dietary lignan intakes and risk of breast cancer by tumor estrogen receptor status.

McCann SE, Kulkarni S, Trevisan M, Vito D, Nie J, Edge SB, Muti P, Freudenheim JL. McCann SE, et al. Among authors: edge sb. Breast Cancer Res Treat. 2006 Oct;99(3):309-11. doi: 10.1007/s10549-006-9196-x. Epub 2006 Mar 16. Breast Cancer Res Treat. 2006. PMID: 16541305

2

Endometrial carcinoma associated with breast carcinoma: low incidence with tamoxifen use.

Cuenca RE, Giachino J, Arredondo MA, Hempling R, Edge SB. Cuenca RE, et al. Among authors: edge sb. Cancer. 1996 May 15;77(10):2058-63. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2058::AID-CNCR14>3.0.CO;2-U. Cancer. 1996. PMID: 8640670

3

Cellular proliferative activity of mammographic normal dense and fatty tissue determined by DNA S phase percentage.

Stomper PC, Penetrante RB, Edge SB, Arredondo MA, Blumenson LE, Stewart CC. Stomper PC, et al. Among authors: edge sb. Breast Cancer Res Treat. 1996;37(3):229-36. doi: 10.1007/BF01806504. Breast Cancer Res Treat. 1996. PMID: 8825134

4

Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion.

Asch HL, Winston JS, Edge SB, Stomper PC, Asch BB. Asch HL, et al. Among authors: edge sb. Breast Cancer Res Treat. 1999 May;55(2):179-88. doi: 10.1023/a:1006203632228. Breast Cancer Res Treat. 1999. PMID: 10481945

5

Downregulation of gelsolin correlates with the progression to breast carcinoma.

Winston JS, Asch HL, Zhang PJ, Edge SB, Hyland A, Asch BB. Winston JS, et al. Among authors: edge sb. Breast Cancer Res Treat. 2001 Jan;65(1):11-21. doi: 10.1023/a:1006446108411. Breast Cancer Res Treat. 2001. PMID: 11245335

6

Altered expression and localization of PKC eta in human breast tumors.

Masso-Welch PA, Winston JS, Edge S, Darcy KM, Asch H, Vaughan MM, Ip MM. Masso-Welch PA, et al. Breast Cancer Res Treat. 2001 Aug;68(3):211-23. doi: 10.1023/a:1012265703669. Breast Cancer Res Treat. 2001. PMID: 11727958

7

Breast cancer risk factors and HER2 over-expression in tumors.

Swede H, Moysich KB, Freudenheim JL, Quirk JT, Muti PC, Hurd TC, Edge SB, Winston JS, Michalek AM. Swede H, et al. Among authors: edge sb. Cancer Detect Prev. 2001;25(6):511-9. Cancer Detect Prev. 2001. PMID: 12132871

8

Patient and provider characteristics that affect the use of axillary dissection in older women with stage I-II breast carcinoma.

Edge SB, Gold K, Berg CD, Meropol NJ, Tsangaris TN, Gray L, Petersen BM Jr, Hwang YT, Mandelblatt JS; Outcomes and Preferences for Treatment in Older Women Nationwide Study Research Team. Edge SB, et al. Cancer. 2002 May 15;94(10):2534-41. doi: 10.1002/cncr.10540. Cancer. 2002. PMID: 12173318 Free article.

9

Provider case volume and outcome in the evaluation and treatment of patients with mammogram-detected breast carcinoma.

McKee MD, Cropp MD, Hyland A, Watroba N, McKinley B, Edge SB. McKee MD, et al. Among authors: edge sb. Cancer. 2002 Aug 15;95(4):704-12. doi: 10.1002/cncr.10737. Cancer. 2002. PMID: 12209712 Free article.

10

Variation of the prognostic significance of HER-2 expression in breast cancer according to tumor size.

Swede H, Moysich KB, Winston JS, Hurd TC, Edge SB, Romero-Gutierrez M, Brooks JS, Michalek AM. Swede H, et al. Among authors: edge sb. Breast J. 2003 Mar-Apr;9(2):98-105. doi: 10.1046/j.1524-4741.2003.09207.x. Breast J. 2003. PMID: 12603382

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

262 results

Search Page

Filters